Tiziana Life Sciences PLC (AIM:TILS) acquired an exclusive world-wide license from NI-1201 of Novimmune SA on January 3, 2017. As part of consideration, Tiziana Life Sciences agreed to an upfront cash payment, milestone payments, and a royalty on future sales. Liam Murray of Cairn Financial Advisers LLP served as financial advisor to Tiziana Life Sciences PLC. Simon Conway and Natalie Garland-Collins of FTI Consulting acted as PR advisors to Tiziana. Tiziana Life Sciences PLC (AIM:TILS) completed the acquisition of an exclusive world-wide license from NI-1201 of Novimmune SA on January 3, 2017. An upfront payment of $0.1 million was paid in February 2017.